Hypertonic saline
FDA Approved
Contents
Description
Hypertonic saline ophthalmic solution is used to reduce corneal edema by drawing excess fluid out of the cornea through osmotic action. It provides temporary relief of corneal swelling and associated visual disturbances. In Harboyan syndrome, characterized by congenital hereditary endothelial dystrophy, hypertonic saline is a first-line symptomatic treatment for corneal edema.
Indications & Therapeutic Use
corneal edema, bullous keratopathy
Linked Diseases:
Harboyan syndrome
C535473
Global Availability (7 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Hypertonic saline — GNH India
828 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP
300 MGsolutionCANADA
(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP
900 MGsolutionCANADA
(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP
900 MGsolutionCANADA
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP
450 MGsolutionCANADA
(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP
900 MGliquidCANADA
(40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP
450 MGsolutionCANADA
0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP
200 MGsolutionUNITED STATES
0.45% SODIUM CHLORIDE INJECTION USP
4.5 MGsolutionUNITED STATES
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Hypertonic saline
| Generic Name | Hypertonic saline |
| Brands | 1 brand available |
| Active Ingredient | Sodium chloride |
| Drug Class | corneal edema |
| Manufacturer | Bausch + Lomb |
| Dosage Forms | Ophthalmic solution, 5%; Ophthalmic ointment, 5% |
| Medical Code | S01XA03 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved |
| Countries | 7 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations8 Validated Nodes